Apeiron RIA’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$477K Sell
1,148
-956
-45% -$354K 0.12% 104
2026
Q1
$569K Sell
2,104
-16
-0.8% -$4.76K 0.13% 111
2025
Q4
$606K Sell
2,120
-35
-2% -$11.9K 0.12% 105
2025
Q3
$773K Sell
2,155
-635
-23% -$192K 0.17% 97
2025
Q2
$870K Sell
2,790
-167
-6% -$63.8K 0.22% 86
2025
Q1
$1.55M Sell
2,957
-18
-0.6% -$9.2K 0.47% 53
2024
Q4
$1.5M Hold
2,975
0.42% 52
2024
Q3
$1.74M Buy
2,975
+198
+7% +$112K 0.5% 41
2024
Q2
$1.41M Buy
2,777
+93
+3% +$45.6K 0.43% 47
2024
Q1
$1.33M Buy
2,684
+13
+0.5% +$6.61K 0.38% 50
2023
Q4
$1.41M Buy
2,671
+44
+2% +$23.5K 0.44% 47
2023
Q3
$1.32M Buy
2,627
+37
+1% +$18.2K 0.45% 45
2023
Q2
$1.24M Buy
2,590
+9
+0.3% +$4.4K 0.43% 45
2023
Q1
$1.22M Buy
2,581
+20
+0.8% +$9.65K 0.42% 47
2022
Q4
$1.36M Buy
2,561
+22
+0.9% +$11.7K 0.52% 43
2022
Q3
$1.27M Buy
2,539
+21
+0.8% +$11K 0.58% 36
2022
Q2
$395 Buy
2,518
+80
+3% +$40.2K 0.11% 77
2022
Q1
$1.31M Buy
2,438
+24
+1% +$11.6K 0.62% 36
2021
Q4
$1.21M Buy
+2,414
New +$1.09M 0.5% 46

Other funds holding UNH

Apeiron RIA's UNH Position: Q2 2026 in Review

Apeiron RIA reduced its UnitedHealth (UNH) stake by 45% in Q2 2026, selling an estimated $354K and leaving 1,148 shares worth $477K. The position accounts for 0.12% of the portfolio, ranked #104.

Apeiron RIA first reported a position in UNH in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.74M in Q3 2024. 702 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Apeiron RIA held 1,148 shares of UnitedHealth worth $477K as of Q2 2026.
  • Apeiron RIA sold 956 UnitedHealth shares in Q2 2026, an estimated $354K.
  • UnitedHealth made up 0.12% of Apeiron RIA's portfolio in Q2 2026, its #104 holding.
  • Apeiron RIA first reported a position in UnitedHealth in Q4 2021 and has held it in 19 quarters since.
  • Apeiron RIA's UnitedHealth position peaked at $1.74M in Q3 2024.
  • 702 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Apeiron RIA's 13F filing for Q2 2026, filed 16 Jul 2026.